Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Obesity 218Neoplasms 73Breast Neoplasms 66Overweight 65Sexual Dysfunction, Physiological 51Motor Activity 43Polycystic Ovary Syndrome 42Weight Loss 32Mucositis 29Dyspnea 28Prostatic Neoplasms 22Multiple Endocrine Neoplasia Type 1 16Constipation 15Lung Neoplasms 14Endometrial Neoplasms 14Diabetes Mellitus 14Anxiety Disorders 14Sedentary Behavior 13Depression 13Sexual Dysfunctions, Psychological 12Cardiovascular Diseases 12Pain 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Fatigue 10Diabetes Mellitus, Type 2 10Colorectal Neoplasms 10Sexuality 9Obesity, Morbid 9Insulin Resistance 9Head and Neck Neoplasms 9

Interventions

mirogabalin 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × CIPN × Other × Clear all
NCT06711978 2024-12-02

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors

Pusan National University Yangsan Hospital

Phase NA Not yet recruiting
66 enrolled
BreastOther

CIPN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡